Single Nucleotide Polymorphism Genotyping Market is estimated to increase at a growth rate of 21.3% CAGR over the forecast period from 2024 to 2030.
The global Single Nucleotide Polymorphism Genotyping Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Technology (TaqMan SNP Genotyping, Massarray SNP Genotyping, SNP GeneChip Arrays, Others), By End-User (Pharmacogenomics, Diagnostic Field).
An introduction to Single Nucleotide Polymorphism Genotyping Market in 2024
Powering genetic research and personalized medicine, the Single Nucleotide Polymorphisms (SNPs) Genotyping Market offers high-throughput genotyping solutions for detecting and analyzing single nucleotide variations in the human genome. SNPs are the most common type of genetic variation, playing a crucial role in disease susceptibility, drug response, and population genetics. This market encompasses a variety of genotyping platforms, including microarrays, PCR-based assays, and next-generation sequencing technologies, provided by biotechnology companies, academic research institutions, and clinical laboratories. With the increasing understanding of genetic diversity and its implications for health and disease, the demand for SNP genotyping continues to rise, driven by advancements in genomics, bioinformatics, and data analytics. As clinicians and researchers strive to unravel the genetic basis of complex traits and diseases, the Single Nucleotide Polymorphisms Genotyping Market remains essential in supporting precision medicine initiatives and advancing personalized healthcare.
Single Nucleotide Polymorphism Genotyping Market Trend: Shift Towards High-Throughput Genotyping Platforms
A prominent trend in the Single Nucleotide Polymorphism (SNP) Genotyping market is the increasing adoption of high-throughput genotyping platforms for large-scale SNP analysis. As genomics research and personalized medicine applications expand, there's a growing demand for genotyping technologies that can efficiently interrogate thousands to millions of SNPs across the genome. High-throughput platforms such as microarrays and next-generation sequencing (NGS) enable rapid, cost-effective SNP genotyping, facilitating genome-wide association studies (GWAS), population genetics research, and pharmacogenomics studies. This trend reflects the need for scalable genotyping solutions that can accommodate diverse study designs, sample sizes, and throughput requirements, driving innovation and growth in the SNP genotyping market.
Single Nucleotide Polymorphism Genotyping Market Driver: Rise in Genetic Studies and Personalized Medicine Initiatives
A key driver propelling the growth of the Single Nucleotide Polymorphism (SNP) Genotyping market is the rise in genetic studies and personalized medicine initiatives aimed at understanding the genetic basis of complex diseases and tailoring treatments to individual patients. With advances in genomics technology and bioinformatics, there's increasing recognition of the role of SNPs in disease susceptibility, treatment response, and drug metabolism. Genotyping technologies enable the identification and characterization of SNPs associated with disease risk, therapeutic efficacy, and adverse drug reactions, informing clinical decision-making and drug development. This growing demand for SNP genotyping in research and clinical settings drives market growth as stakeholders seek to leverage genetic information for precision medicine approaches and improve patient outcomes.
Single Nucleotide Polymorphism Genotyping Market Opportunity: Expansion into Point-of-Care Testing and Companion Diagnostics
An opportunity in the Single Nucleotide Polymorphism (SNP) Genotyping market lies in the expansion into point-of-care testing (POCT) and companion diagnostics for rapid SNP analysis in clinical settings. As genomics becomes increasingly integrated into routine healthcare, there's a need for decentralized genotyping solutions that can deliver actionable genetic information quickly and accurately at the point of care. POCT devices and companion diagnostic assays for SNP genotyping offer the potential for real-time patient stratification, treatment selection, and monitoring across a wide range of medical specialties, including oncology, cardiology, and infectious diseases. By developing user-friendly, cost-effective SNP genotyping assays compatible with POCT platforms, companies can capitalize on the growing demand for personalized diagnostics and expand their market presence in clinical genomics applications.
Single Nucleotide Polymorphism Genotyping Market Market Segmentation
By Technology
TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
Others
By End-User
Pharmacogenomics
Diagnostic Field
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Single Nucleotide Polymorphism Genotyping Market Companies
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Danaher Corp
Douglas Scientific LLC
Fluidigm Corp
Illumina Inc
LGC Group
Life Technologies Corp
Luminex Corp
PREMIER Biosoft
Promega Corp
Sequenom
Thermo Fischer Scientific Inc
Reasons to Buy the Single Nucleotide Polymorphism Genotyping Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Single Nucleotide Polymorphism Genotyping Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Single Nucleotide Polymorphism Genotyping Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Single Nucleotide Polymorphism Genotyping Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Single Nucleotide Polymorphism Genotyping Market Size Outlook, $ Million, 2021 to 2030
3.2 Single Nucleotide Polymorphism Genotyping Market Outlook by Type, $ Million, 2021 to 2030
3.3 Single Nucleotide Polymorphism Genotyping Market Outlook by Product, $ Million, 2021 to 2030
3.4 Single Nucleotide Polymorphism Genotyping Market Outlook by Application, $ Million, 2021 to 2030
3.5 Single Nucleotide Polymorphism Genotyping Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Single Nucleotide Polymorphism Genotyping Industry
4.2 Key Market Trends in Single Nucleotide Polymorphism Genotyping Industry
4.3 Potential Opportunities in Single Nucleotide Polymorphism Genotyping Industry
4.4 Key Challenges in Single Nucleotide Polymorphism Genotyping Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Single Nucleotide Polymorphism Genotyping Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Single Nucleotide Polymorphism Genotyping Market Outlook by Segments
7.1 Single Nucleotide Polymorphism Genotyping Market Outlook by Segments, $ Million, 2021- 2030
By Technology
TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
Others
By End-User
Pharmacogenomics
Diagnostic Field
8 North America Single Nucleotide Polymorphism Genotyping Market Analysis and Outlook To 2030
8.1 Introduction to North America Single Nucleotide Polymorphism Genotyping Markets in 2024
8.2 North America Single Nucleotide Polymorphism Genotyping Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Single Nucleotide Polymorphism Genotyping Market size Outlook by Segments, 2021-2030
By Technology
TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
Others
By End-User
Pharmacogenomics
Diagnostic Field
9 Europe Single Nucleotide Polymorphism Genotyping Market Analysis and Outlook To 2030
9.1 Introduction to Europe Single Nucleotide Polymorphism Genotyping Markets in 2024
9.2 Europe Single Nucleotide Polymorphism Genotyping Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Single Nucleotide Polymorphism Genotyping Market Size Outlook by Segments, 2021-2030
By Technology
TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
Others
By End-User
Pharmacogenomics
Diagnostic Field
10 Asia Pacific Single Nucleotide Polymorphism Genotyping Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Single Nucleotide Polymorphism Genotyping Markets in 2024
10.2 Asia Pacific Single Nucleotide Polymorphism Genotyping Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Single Nucleotide Polymorphism Genotyping Market size Outlook by Segments, 2021-2030
By Technology
TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
Others
By End-User
Pharmacogenomics
Diagnostic Field
11 South America Single Nucleotide Polymorphism Genotyping Market Analysis and Outlook To 2030
11.1 Introduction to South America Single Nucleotide Polymorphism Genotyping Markets in 2024
11.2 South America Single Nucleotide Polymorphism Genotyping Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Single Nucleotide Polymorphism Genotyping Market size Outlook by Segments, 2021-2030
By Technology
TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
Others
By End-User
Pharmacogenomics
Diagnostic Field
12 Middle East and Africa Single Nucleotide Polymorphism Genotyping Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Single Nucleotide Polymorphism Genotyping Markets in 2024
12.2 Middle East and Africa Single Nucleotide Polymorphism Genotyping Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Single Nucleotide Polymorphism Genotyping Market size Outlook by Segments, 2021-2030
By Technology
TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
Others
By End-User
Pharmacogenomics
Diagnostic Field
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Danaher Corp
Douglas Scientific LLC
Fluidigm Corp
Illumina Inc
LGC Group
Life Technologies Corp
Luminex Corp
PREMIER Biosoft
Promega Corp
Sequenom
Thermo Fischer Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Technology
TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
Others
By End-User
Pharmacogenomics
Diagnostic Field
